The legal action, brought by the law firm Bronstein, Gewirtz & Grossman, LLC, targets the NASDAQ-listed company on behalf of shareholders who acquired securities between December 27, 2024, and July 8, 2025. According to the filing, the company’s initial public offering was intentionally engineered with an exceptionally low public float, creating conditions for market manipulation and social media-driven misinformation.
Park Ha Biological Technology Faces Class Action Over Stock Manipulation
A federal class action lawsuit has been filed against Park Ha Biological Technology Co., Ltd., alleging the firm misled investors through a fraudulent stock promotion scheme. The complaint claims the company failed to disclose artificial trading activity and misinformation campaigns that inflated its stock price during the first half of 2025.
Investors who incurred losses during this period have until September 21, 2026, to petition the court for lead plaintiff status. While the firm operates on a contingency fee basis—seeking reimbursement only upon a successful recovery—they emphasize that participation in the litigation does not strictly require serving as a lead plaintiff. Those interested in reviewing the full complaint or contacting the legal team can find details through the firm's dedicated portal or by calling 917-590-0911.
Comments (0)
No comments yet. Be the first!